Contract Manufacturing

Each year, on November 14, World Diabetes Day (WDD) is recognized around the world. WDD was created in 1991 in response to growing concerns about the escalating health threat posed by diabetes. It is the world’s largest diabetes awareness campaign, reaching a global audience of over 1 billion people in more than 160 countries.

In today’s increasingly complex drug delivery and device development landscape, a reliable contract manufacturing partner can become a distinct competitive advantage for pharmaceutical and device companies. West brings together the right combination of insights and infrastructure to help our customers reduce costs, mitigate risk and accelerate path to market.

West is pleased to announce the launch of its Integrated Solutions program – a comprehensive approach that combines West’s high-quality packaging and delivery products with our expert analytical testing, fill-finish services, device assembly and manufacturing, and regulatory support.

With the prevalence of Non-alcoholic Steatohepatitis (NASH) rapidly increasing globally, West is working with its pharmaceutical partners to support their development of new injectable treatments for this serious liver condition. However, there are many challenges associated with trying to bring new treatments to market.

For the pharmaceutical industry, the cost of developing new and innovative therapies will continue to rise (the cost of developing a drug is now estimated to be between $1.5 billion to more than $1.8 billion¹).

As noted previously, certain drugs require cold storage in order to maintain efficacy for delivery to patients.  A well-monitored cold chain can help to ensure that drugs are properly handled throughout storage and transportation. But how can a manufacturer prove that the drugs are maintained and controlled adequately in a cold environment?